IN2012DN04918A - - Google Patents

Download PDF

Info

Publication number: IN2012DN04918A
Authority: IN; India
Prior art keywords: skin; nucleic acid; polypeptides; various; exfoliation
Prior art date: 2009-11-30

Application number

Other languages

English (en)

Inventor

Hans Kristian Leren

Bernt Walther

Original Assignee

Aqua Bio Technology Asa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-30

Filing date

2010-11-30

Publication date

2015-09-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41572950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN04918(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-11-30 Application filed by Aqua Bio Technology Asa filed Critical Aqua Bio Technology Asa

2015-09-25 Publication of IN2012DN04918A publication Critical patent/IN2012DN04918A/en

Links

150000007523 nucleic acids Chemical group 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
102000004196 processed proteins & peptides Human genes 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
241000251468 Actinopterygii Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
238000004299 exfoliation Methods 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
230000012447 hatching Effects 0.000 abstract 1
230000003020 moisturizing effect Effects 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
208000017520 skin disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1706—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
- C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
- C12N9/6416—Metalloendopeptidases (3.4.24)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24066—Choriolysin L (3.4.24.66)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Birds (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Immunology (AREA)
Marine Sciences & Fisheries (AREA)
Toxicology (AREA)
Biophysics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Cosmetics (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Absorbent Articles And Supports Therefor (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Detergent Compositions (AREA)

IN4918DEN2012 2009-11-30 2010-11-30 IN2012DN04918A (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0921001A GB0921001D0 (en)	2009-11-30	2009-11-30	Products and uses
PCT/EP2010/068509 WO2011064384A1 (en)	2009-11-30	2010-11-30	Hatching fluid enzymes and uses thereof

Publications (1)

Publication Number	Publication Date
IN2012DN04918A true IN2012DN04918A (de)	2015-09-25

Family

ID=41572950

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN4918DEN2012 IN2012DN04918A (de)	2009-11-30	2010-11-30

Country Status (17)

Country	Link
US (3)	US9133256B2 (de)
EP (1)	EP2506825B2 (de)
JP (1)	JP5913117B2 (de)
KR (1)	KR101842521B1 (de)
CN (2)	CN102724954B (de)
AU (2)	AU2010323022B2 (de)
CA (1)	CA2781834C (de)
CL (1)	CL2012001380A1 (de)
ES (1)	ES2741586T5 (de)
GB (1)	GB0921001D0 (de)
IN (1)	IN2012DN04918A (de)
MX (1)	MX340231B (de)
NZ (2)	NZ627941A (de)
PL (1)	PL2506825T5 (de)
RU (1)	RU2595399C2 (de)
WO (1)	WO2011064384A1 (de)
ZA (1)	ZA201204066B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201110783D0 (en) *	2011-06-24	2011-08-10	Aqua Bio Technology Asa	Methods and uses
GB201110777D0 (en) *	2011-06-24	2011-08-10	Aqua Bio Technology Asa	Methods and uses
MX346043B (es) *	2012-01-06	2017-03-03	Novus Int Inc	Tensioactivos basados en sulfoxido.
PL3100717T3 (pl) *	2012-01-23	2022-04-19	Restorsea, Llc	Kosmetyk zawierający izolat białka z ikry ryb
GB201223330D0 (en) *	2012-12-21	2013-02-06	Aqua Bio Technology Asa	Products, methods and uses
CN105025906B (zh) *	2012-12-21	2020-08-25	阿克生物科技公司	来自鱼孵化液的化妆品组合物
KR101505294B1 (ko) *	2013-06-19	2015-03-23	강릉원주대학교산학협력단	켈로이드 또는 흉터 형성을 감소시키기 위한 조성물
EP3091961A4 (de)	2013-12-13	2017-11-15	Restorsea, LLC	Exfolierende formulierungen zur förderung der haarbewahrung
WO2015175333A1 (en)	2014-05-16	2015-11-19	Restorsea, Llc	Biphasic cosmetic
US10584306B2 (en)	2017-08-11	2020-03-10	Board Of Regents Of The University Of Oklahoma	Surfactant microemulsions
CN114727934A (zh) *	2019-07-05	2022-07-08	雷杰尼斯有限公司	伤口清创系统
CN110592054B (zh) *	2019-08-29	2021-02-12	中国科学院南海海洋研究所	海马孵化酶基因及其编码蛋白和应用
KR20240100757A (ko) *	2022-12-23	2024-07-02	순천향대학교 산학협력단	철갑상어 점액질을 유효성분으로 포함하는 상처 치유 또는 여드름 치료용 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3393559B2 (ja) *	1993-10-15	2003-04-07	株式会社ノエビア	皮膚外用剤
FR2743723B1 (fr)	1996-01-18	1998-04-17	Texinfine Sa	Utilisation d'extrait des plantes de la famille des dictyotales en vue de la realisation de preparations destinees a remanier les elements glycosyles de la matrice extracellulaire de tissus vivants
NO314594B1 (no)	1997-12-11	2003-04-14	Aqua Bio Technology As	Ikke-selvdegraderende endoprotease, fremgangsmåte for fremstilling samt anvendelser av denne
WO1999062315A2 (en)	1998-05-27	1999-12-02	Lauras As	Method for altering the activity of proteins of the pka signaling pathway
FR2792202B1 (fr) *	1999-04-19	2003-06-13	Pharmascience Lab	Extrait peptidique de lupin et composition pharmaceutique ou cosmetique ou nutraceutique comprenant un tel extrait
US20030166902A1 (en) *	2001-02-20	2003-09-04	Yi Hu	Novel human protease and polynucleotides encoding the same
JP4643800B2 (ja)	2000-06-16	2011-03-02	エム・ディジャパン株式会社	プロテアーゼ阻害剤
US20050074865A1 (en) †	2002-08-27	2005-04-07	Compound Therapeutics, Inc.	Adzymes and uses thereof
GB0230006D0 (en)	2002-12-23	2003-01-29	Ares Trading Sa	Proteins
US20040180025A1 (en) *	2003-03-12	2004-09-16	New Life Resources, Llc	Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
CA2544820C (en) *	2003-11-06	2014-02-18	Genencor International, Inc.	Bacterial expression of protease inhibitors and variants thereof
EP1689766B1 (de)	2003-11-06	2012-04-25	Danisco US Inc.	Expression von proteaseinhibitoren und varianten davon in filamentösen pilzen
US8357365B2 (en) *	2005-02-14	2013-01-22	The Regents Of The University Of California	Granulysin peptides and methods of use thereof
JP2008094726A (ja)	2006-10-06	2008-04-24	Towa Koso Kk	マイクロバブル洗浄用組成物、マイクロバブル洗浄方法及びマイクロバブル洗浄装置

2009
- 2009-11-30 GB GB0921001A patent/GB0921001D0/en not_active Ceased
2010
- 2010-11-30 IN IN4918DEN2012 patent/IN2012DN04918A/en unknown
- 2010-11-30 KR KR1020127016994A patent/KR101842521B1/ko not_active Expired - Fee Related
- 2010-11-30 ES ES10784313T patent/ES2741586T5/es active Active
- 2010-11-30 EP EP10784313.8A patent/EP2506825B2/de active Active
- 2010-11-30 WO PCT/EP2010/068509 patent/WO2011064384A1/en not_active Ceased
- 2010-11-30 NZ NZ62794110A patent/NZ627941A/en not_active IP Right Cessation
- 2010-11-30 JP JP2012540460A patent/JP5913117B2/ja not_active Expired - Fee Related
- 2010-11-30 CN CN201080054198.1A patent/CN102724954B/zh active Active
- 2010-11-30 US US13/511,326 patent/US9133256B2/en active Active
- 2010-11-30 CN CN201410670596.6A patent/CN104436163B/zh active Active
- 2010-11-30 PL PL10784313.8T patent/PL2506825T5/pl unknown
- 2010-11-30 NZ NZ60049910A patent/NZ600499A/en not_active IP Right Cessation
- 2010-11-30 RU RU2012127298/10A patent/RU2595399C2/ru active
- 2010-11-30 AU AU2010323022A patent/AU2010323022B2/en not_active Ceased
- 2010-11-30 CA CA2781834A patent/CA2781834C/en active Active
- 2010-11-30 MX MX2012006090A patent/MX340231B/es active IP Right Grant
2012
- 2012-05-29 CL CL2012001380A patent/CL2012001380A1/es unknown
- 2012-06-04 ZA ZA2012/04066A patent/ZA201204066B/en unknown
2015
- 2015-04-21 AU AU2015202010A patent/AU2015202010B2/en not_active Ceased
- 2015-07-30 US US14/813,390 patent/US9624483B2/en not_active Expired - Fee Related
2017
- 2017-03-06 US US15/450,479 patent/US9950031B2/en active Active

Also Published As

Publication number	Publication date
EP2506825B1 (de)	2019-05-08
US9624483B2 (en)	2017-04-18
KR20120115291A (ko)	2012-10-17
EP2506825B2 (de)	2023-05-31
CN104436163A (zh)	2015-03-25
MX2012006090A (es)	2012-09-07
PL2506825T5 (pl)	2023-07-10
US9950031B2 (en)	2018-04-24
PL2506825T3 (pl)	2019-11-29
NZ627941A (en)	2015-01-30
AU2015202010A1 (en)	2015-05-14
US20120309689A1 (en)	2012-12-06
JP5913117B2 (ja)	2016-04-27
RU2595399C2 (ru)	2016-08-27
ES2741586T3 (es)	2020-02-11
CN104436163B (zh)	2017-08-11
CL2012001380A1 (es)	2012-11-30
US20170189478A1 (en)	2017-07-06
WO2011064384A1 (en)	2011-06-03
BR112012012909A2 (pt)	2017-04-18
AU2015202010B2 (en)	2017-04-20
EP2506825A1 (de)	2012-10-10
US9133256B2 (en)	2015-09-15
ES2741586T5 (es)	2023-08-18
RU2012127298A (ru)	2014-01-20
US20160053249A1 (en)	2016-02-25
KR101842521B1 (ko)	2018-03-27
CA2781834C (en)	2019-02-12
CN102724954A (zh)	2012-10-10
JP2013511971A (ja)	2013-04-11
CN102724954B (zh)	2018-07-27
GB0921001D0 (en)	2010-01-13
NZ600499A (en)	2014-09-26
AU2010323022B2 (en)	2015-05-14
AU2010323022A1 (en)	2012-06-21
ZA201204066B (en)	2013-08-28
CA2781834A1 (en)	2011-06-03
MX340231B (es)	2016-07-01

Publication	Publication Date	Title
MX340231B (es)	2016-07-01	Enzimas fluidas incubadas y usos de las mismas.
WO2009080306A8 (en)	2011-02-24	Anti-dandruff compositions containing peptides
MX339201B (es)	2016-05-13	Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
EP3747457A3 (de)	2021-03-03	Faktor-1-protein, faktor-2-protein und inhibitoren davon zur verwendung bei der behandlung und prävention von erkrankungen
EA201591281A1 (ru)	2016-02-29	Рибонуклеиновые кислоты с 4'-тиомодифицированными нуклеотидами и связанные с ними способы
ZA201202705B (en)	2013-06-26	Peptides used in the treatment and/or care of the skin.mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
WO2010101742A3 (en)	2011-01-27	Ampholytic ter-polymers for use in personal care compositions
PL2640352T3 (pl)	2017-12-29	Hydrolizat kolagenu do zastosowania do poprawy zdrowia ludzkiej skóry, włosów i/lub paznokci
IL215503A0 (en)	2011-12-29	Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
CY1118813T1 (el)	2018-03-07	Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων
HRP20190059T1 (hr)	2019-03-08	Pripravci za liječenje boli i/ili upale
EP2528603A4 (de)	2013-09-04	Pharmazeutische zusammensetzungen zur behandlung von schmerz und anderen anzeigen
BR112014019431A8 (pt)	2017-07-11	Método compartimentalizado de distribuição de ácido nucleico e composições e usos desses
BR112015014532A2 (pt)	2017-10-10	composições cosméticas de fluido de eclosão de peixe
MX2009004243A (es)	2009-05-14	Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
EA201391119A1 (ru)	2014-01-30	Системы доставки наночастиц, их получение и применение
IL251543A0 (en)	2017-05-29	Use of a topical gel composition in the manufacture of a medicament for the prevention or treatment of a skin disorder
BR112014019623A8 (pt)	2017-07-11	Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina
IL234101B (en)	2019-09-26	Compositions comprising acamprosate and baclofen for use in the treatment of parkinsonism
EP2633052A4 (de)	2014-01-29	Behandlung ifrd1-vermittelter erkrankungen durch hemmung des natürlichen antisense-transkripts gegen ifrd1
IT1405793B1 (it)	2014-01-24	Molecola di u1snrna umano modificato, gene codificante per la molecola di u1snrna umano modificato, vettore di espressione includente il gene, e loro uso in terapia genica
EP2415476A4 (de)	2012-12-05	Zusammensetzung zur vorbeugung und/oder behandlung von hautkrankheiten
EA200970154A1 (ru)	2009-06-30	Косметические или дерматологические препараты, содержащие n-ацетилцистеин
EA201690659A1 (ru)	2016-10-31	Композиции аморфного магнийзамещенного фосфата кальция и их применение
ATE500265T1 (de)	2011-03-15	Synthetische mecp2-sequenz für die proteinersatztherapie